Irene L Andrulis

researcher

Irene L Andrulis is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-4226-6435

P27country of citizenshipCanadaQ16
P108employerUniversity of TorontoQ180865
P735given nameIreneQ389528
IreneQ389528
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q6411528410-year performance of four models of breast cancer risk: a validation study
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q338488952q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q36029709A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
Q59355837A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk
Q35957063A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
Q37272982A genome wide linkage search for breast cancer susceptibility genes
Q29417036A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.
Q35889669A genome-wide linkage study of mammographic density, a risk factor for breast cancer
Q36577115A high-resolution copy-number variation resource for clinical and population genetics
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q35089479A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
Q34521165A mutant PTH/PTHrP type I receptor in enchondromatosis
Q92711687A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
Q36152991A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers
Q81234958A pilot genome-wide association study of early-onset breast cancer
Q39982410A qualitative study evaluating parental attitudes towards the creation of a female youth cohort (LEGACY) in the Breast Cancer Family Registry
Q35063910A role for asparaginyl-tRNA in the regulation of asparagine synthetase in a mammalian cell line
Q30489618A role for the TGFbeta-Par6 polarity pathway in breast cancer progression
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q36043159ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry
Q37417780AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study
Q37700795Aberrant hedgehog signaling and clinical outcome in osteosarcoma
Q37218002Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry
Q114612672Abstract 1395: Identification of genes and pathways related to lymphovascular invasion in axillary-node negative breast cancer: A bioinformatic analysis of gene expression data
Q58074718Abstract 4593: Genome-wide association study identifies novel loci associated with osteosarcoma
Q58074642Abstract 5574: High prevalence of germline TP53 mutations in young osteosarcoma cases
Q92102602Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool
Q36497745Accuracy of Self-Reported Breast Cancer Information among Women from the Ontario Site of the Breast Cancer Family Registry
Q37105163Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry
Q35231571Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q58613780Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
Q91618412Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium
Q91518331Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)
Q79703376Alcohol metabolism, alcohol intake, and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry
Q28299137Altered expression and deletion of RMO1 in osteosarcoma
Q48485483Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Q51024001Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.
Q36073563An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression
Q46063050An inverse association between ovarian cysts and breast cancer in the breast cancer family registry
Q35618307An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
Q68184562Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas
Q24170413Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Q35605807Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study
Q35753119Analysis of mRNA from microdissected frozen tissue sections without RNA isolation
Q33229208Application of reliability coefficients in cDNA microarray data analysis
Q39282400Asparaginyl-tRNA aminoacylation levels and asparagine synthetase expression in cultured Chinese hamster ovary cells
Q35242849Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q64940233Assessing patient readiness for personalized genomic medicine.
Q57937919Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival
Q35218520Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q27851709Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer
Q91271723Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
Q36072765Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
Q64112402Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer
Q36178189Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Q37684672Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q114182713Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Q99609984Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer
Q46121002Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
Q34801008Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Q35957703Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
Q119213340Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35523236Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q35416040Atypical protein kinase C zeta: potential player in cell survival and cell migration of ovarian cancer
Q92904333Authors' response: Associations of obesity and circulating insulin and glucose with breast cancer risk
Q64039257BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry
Q37416050BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research
Q34571646BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Q36621949BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
Q74449532BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases
Q38914005BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
Q37002955BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Q42506232BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays
Q34334167Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry
Q91375393Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort
Q42802070Biochemical characterization of a mutant asparaginyl-tRNA synthetase from Chinese hamster ovary cells
Q35599920Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Q46036353Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.
Q46115524Body mass index and breast cancer survival: a Mendelian randomization analysis
Q50046604Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study.
Q100457582Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
Q57265621Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study
Q114182645Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores
Q34327945Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Q35609710Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry
Q37410693Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab
Q35940158Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Q33767889Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?
Q57305977Breast-Cancer Risk in Families With Mutations in PALB2
Q34148873Breast-cancer risk in families with mutations in PALB2
Q41667015CD10 and CD44 genes of leukemic cells and malignant cell lines show no evidence of transformation-related alterations
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q35050626CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registry
Q79967598COPS3 amplification and clinical outcome in osteosarcoma
Q92005489Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Q114657791Cancer Risks Associated With and Pathogenic Variants
Q34963894Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Q24329205Cell cycle regulated phosphorylation of LIMD1 in cell lines and expression in human breast cancers
Q38421601Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
Q44173416Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies
Q43742885Characterization of single step albizziin-resistant Chinese hamster ovary cell lines with elevated levels of asparagine synthetase activity
Q45065658Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma
Q96962174Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Q36937122Chromosomal Alterations Associated with Overproduction of Asparagine Synthetase in Albizziin-Resistant Chinese Hamster Ovary Cells
Q36997687Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers
Q79269372Cloning and mutation analysis of ZFP276 as a candidate tumor suppressor in breast cancer
Q34492917Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas
Q37219731Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)
Q94486442Combined associations of a polygenic risk score and classical risk factors with breast cancer risk
Q33314644Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk
Q37368000Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms
Q101133507Common Childhood Viruses and Pubertal Timing: The LEGACY Girls Study
Q36839777Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
Q34394665Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction
Q35889575Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Q36600605Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk
Q24655824Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
Q33742096Common genetic variants and modification of penetrance of BRCA2-associated breast cancer
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q36393232Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers
Q35870067Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Q37434133Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Q115209587Common variants in breast cancer risk loci predispose to distinct tumor subtypes
Q34213403Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Q104263819Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q37047463Comparison of Clinical, Maternal, and Self Pubertal Assessments: Implications for Health Studies
Q40718941Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations
Q52579925Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer.
Q74610152Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q90481059Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results
Q35070800Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation
Q35029565Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry
Q89897900Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
Q57266620Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
Q45793899Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer.
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q91090014Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers
Q34084261Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study
Q41365367Correlation of p-glycoprotein detection by immunohistochemistry with mdr-1 mRNA levels in osteosarcomas. Pilot study
Q21144874DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers
Q36769488DNA methylation patterns associated with asparagine synthetase expression in asparagine-overproducing and -auxotrophic cells
Q37685729DNA mismatch repair gene MSH6 implicated in determining age at natural menopause
Q71814442Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET
Q23916196Detectable clonal mosaicism and its relationship to aging and cancer
Q80153079Detection and typing of human papillomavirus in verrucous carcinoma of the oral cavity using the polymerase chain reaction
Q33588213Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers
Q38927282Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry
Q43591191Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information
Q35049656Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry
Q38444030E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast
Q37843728EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry
Q87374141ERβ splice variant expression in four large cohorts of human breast cancer patient tumors
Q54158232EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Q27851507EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma
Q42518726Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer
Q28288212Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis
Q46576086Erratum to: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
Q93484362Erratum to: PATCHED-ONE or SMOOTHENED Gene Mutations Are Infrequent in Chondrosarcoma
Q47331743Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire
Q33614244Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
Q37481884Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
Q91549968Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk
Q36352389Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers
Q37745041Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers
Q33894527Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium
Q35653910Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q41004639Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma
Q38318239Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours
Q34708024Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors
Q54242131Expression of the multidrug resistance gene in osteosarcoma: a pilot study.
Q41260882Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage.
Q37306967Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors
Q37594336FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Q33967959Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model
Q24539146Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene
Q37308563Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry
Q45137915Family-based association study of IGF1 microsatellites and height, weight, and body mass index
Q51811339Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q35158606Fine structure analysis of the Chinese hamster AS gene encoding asparagine synthetase
Q36111237Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Q36087170Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q39844032Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Q36248936Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q44023983Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations
Q88096707Fresh Cut Versus Stored Cut Paraffin-embedded Tissue: Effect on Immunohistochemical Staining for Common Breast Cancer Markers
Q114182808Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Q57419070Functional characterization of novel presenilin-2 variants identified in human breast cancers
Q36124728Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q90824840Gene-based and pathway-based testing for rare-variant association in affected sib pairs
Q35832873Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility
Q35999323Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study
Q108609948Genetic insights into biological mechanisms governing human ovarian ageing
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q29417068Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q52561250Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
Q33811527Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation
Q44743159Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry
Q35022825Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q36422109Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Q30000080Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Q92387949Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent
Q37364660Genome wide screening of CAG trinucleotide repeat lengths in breast cancer
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q63681757Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q95329367Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Q46904091Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients
Q28659642Genome-wide association study identifies two susceptibility loci for osteosarcoma
Q27008356Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q38436572Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast
Q59566871Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility
Q38823212Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
Q36465250Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer
Q44314670Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
Q96432094Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
Q36294747Germline TP53 variants and susceptibility to osteosarcoma.
Q59756250Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer
Q35114576Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
Q34414768Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
Q34643959Global DNA methylation levels in girls with and without a family history of breast cancer
Q44202163HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry
Q54600960HER2 and responsiveness of breast cancer to adjuvant chemotherapy.
Q80463670HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab
Q35382206Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
Q57471595Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q71257737Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation
Q43812884Histidyl-tRNA synthetase of Chinese hamster ovary cells contains phosphoserine
Q41961367Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
Q34522623Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families
Q41698482Hypomethylation and reactivation of the asparagine synthetase gene induced by L-asparaginase and ethyl methanesulfonate
Q35448920Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q30252854Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Q36720814Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
Q39321320Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site
Q36859142Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Q35608709Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q47161199Identification of new breast cancer predisposition genes via whole exome sequencing
Q34038964Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Q36014067Identification of novel genetic markers of breast cancer survival
Q28250209Identification of rare variants in the hLIMD1 gene in breast cancer
Q35541663Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q48005435Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Q112712388Immuno-transcriptomic profiling of extracranial pediatric solid malignancies
Q51196865Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.
Q23924183Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Q114184688Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Q34250215Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
Q35443535Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies
Q35013740Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry
Q51776187Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
Q37410472Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q38102971Insights from mixture cure modeling of molecular markers for prognosis in breast cancer
Q41392155Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas.
Q36742137Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility
Q45191001Invasive lobular carcinoma: to grade or not to grade
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q39073113Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma
Q24293651Isolation of human cDNAs for asparagine synthetase and expression in Jensen rat sarcoma cells
Q42521302JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer
Q34392980LAF-4 is aberrantly expressed in human breast cancer
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q43843244Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction
Q112644625Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
Q77556033Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q24315119MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
Q54044595MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.
Q31043651Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Q38463411Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry
Q35674829Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
Q92860654Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
Q114182490Mendelian randomisation study of smoking exposure in relation to breast cancer risk
Q37293236Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
Q36747465Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer
Q55216953Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry.
Q72333528Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacement
Q33915724Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q35207476Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes
Q33718631Molecular alterations in bone and soft-tissue sarcoma.
Q41756370Molecular and genetic characterization of human cell lines resistant to L-asparaginase and albizziin
Q71568948Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas
Q54334754Molecular genetic changes in musculoskeletal sarcomas.
Q48300558Molecular structure of the human asparagine synthetase gene
Q46988962Molecular variants of the thiazide-sensitive Na+-Cl- cotransporter in hypertensive families
Q24658557Multigene testing of moderate-risk genes: be mindful of the missense
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q71908877Multiplex PCR-SSCP for simultaneous screening for mutations in several exons of p53
Q73205349Mutation in the coding region of the BRCA1 gene leads to aberrant splicing of the transcript
Q49024646Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations.
Q73939659Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations
Q36479856New Ontario familial breast cancer registry to facilitate genetic and epidemiologic studies
Q37356243Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Q37237352No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q37079859No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Q44122211No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years
Q37628084Non-invasive optical spectroscopic monitoring of breast development during puberty
Q35752042Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures
Q36696565Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
Q34398269Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations
Q36280191Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Q41545887Overexpression of asparagine synthetase in albizziin-resistant murine diploid embryonic stem cells
Q53400474P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q40070779Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.
Q34289136Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Q34061135Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry
Q41330027Patched-one or smoothened gene mutations are infrequent in chondrosarcoma
Q112572520Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Q35737888Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Q37307937Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium
Q39429341Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
Q72230768Phase I-II study of vinblastine and oral cyclosporin A in metastatic renal cell carcinoma
Q47975546Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q97524107Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
Q38342760Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
Q33287624Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q45062920Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry
Q100562109Pre-Pubertal Internalizing Symptoms and Timing of Puberty Onset in Girls
Q37353677Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry
Q36356727Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q47930081Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers
Q42438080Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort
Q45235328Prognostic factors affecting the natural history of node-negative breast cancer
Q36629530Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas
Q42265507Protein kinase C epsilon and genetic networks in osteosarcoma metastasis
Q37149228Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer
Q33781466Pubertal development in girls by breast cancer family history: the LEGACY girls cohort
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q90242034Publisher Correction: Shared heritability and functional enrichment across six solid cancers
Q33796247Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
Q36140996Quantitative analysis of multidrug resistance gene expression in human osteosarcomas
Q36512097RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies
Q34540638RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study
Q36009422RAD51B in Familial Breast Cancer
Q100428113RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors
Q114182625Rare germline copy number variants (CNVs) and breast cancer risk
Q28652308Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study
Q28652056Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers
Q28730692Rare mutations in XRCC2 increase the risk of breast cancer
Q35608690Rare variants in the ATM gene and risk of breast cancer
Q37373918Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer
Q28743906Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
Q60355290Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors
Q90439909Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk
Q40700714Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q34321868Refined localization of the asparagine synthetase gene (ASNS) to chromosome 7, region q21.3, and characterization of the somatic cell hybrid line 4AF/106/KO15.
Q43512760Regression models, scan statistics and reappearance probabilities to detect regions of association between gene expression and copy number
Q64101959Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
Q45951126Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Q37632099Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
Q35750765Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry
Q37085786Risk of pancreatic cancer in breast cancer families from the breast cancer family registry
Q93367394Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
Q92708085Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
Q38717239Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Q71730149SAS is amplified predominantly in surface osteosarcoma
Q36545934SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Q33242109SNP-SNP interactions in breast cancer susceptibility
Q35983751Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry
Q61118451Shared heritability and functional enrichment across six solid cancers
Q64004349Shared heritability and functional enrichment across six solid cancers
Q60613940Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer
Q57591377Statistical challenges in high-dimensional molecular and genetic epidemiology
Q33566957TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Q61909878TP53Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study
Q37122297Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
Q57250694The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Q44930023The APCI1307K allele and breast cancer risk
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q24806109The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer
Q44897750The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry
Q51070817The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario.
Q91178389The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
Q67517633The HER-2/neu oncogene in breast cancer: so what is new?
Q64116004The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With or Mutations
Q37686870The LEGACY Girls Study: Growth and Development in the Context of Breast Cancer Family History
Q35781316The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients
Q37401496The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
Q60487433The association between weight at birth and breast cancer risk revisited using Mendelian randomisation
Q64239462The association between weight at birth and breast cancer risk revisited using Mendelian randomisation
Q28240820The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis
Q75216726The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer
Q38835609The genomic landscape of epithelioid sarcoma cell lines and tumours
Q24306302The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors
Q96609076The long non-coding RNA NEAT1 promotes sarcoma metastasis by regulating RNA splicing pathways
Q35476902The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry
Q35024008The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q37180708Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy
Q54376091Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial.
Q33654997Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry
Q89961489Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
Q90370299Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival
Q36544876Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry
Q37003285Tumour morphology predicts PALB2 germline mutation status
Q92994868Two truncating variants in FANCC and breast cancer risk
Q48073212Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer
Q79553555Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer
Q115601277Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry
Q33520568Using cancer registry data: agreement in cause-of-death data between the Ontario Cancer Registry and a longitudinal study of breast cancer patients
Q40346477Validation of Intratumoral T-bet+ Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer
Q57306005Validation study of thelambdamodel for predicting theBRCA1orBRCA2mutation carrier status of North American Ashkenazi Jewish women
Q33855441Whole-genome amplification enables accurate genotyping for microarray-based high-density single nucleotide polymorphism array
Q36082470Worry is good for breast cancer screening: a study of female relatives from the ontario site of the breast cancer family registry
Q40238696hCDC4 variation in osteosarcoma
Q74463760neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group
Q45080213p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2
Q36622414p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas
Q34083047p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
Q74251183p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
Q40507472von Willebrand factor expression in osteosarcoma metastasis

Search more.